doi:10.1002/ejhf.1355 Online publish-ahead-of-print 23 November 2018
Pulmonary artery wedge pressure respiratory variation is correlated with haemodynamic improvement with increased left ventricular assist system speed Recently, the focus for left ventricular assist system (LVAS) patients has expanded to include quality of life as well as survival. Despite LVAS implantation, many patients have persistent heart failure symptoms, and objective markers of exertional capacity such as peak oxygen consumption may not improve much after LVAS implantation despite overall improvement in haemodynamics. 1 In one cohort of 35 LVAS patients, only 43% had normal central venous pressure (CVP) and/or pulmonary artery wedge pressure (PAWP) at the time of haemodynamic assessment with right heart catheterization (RHC), with 57% achieving normal filling pressures at the end of ramp speed adjustment. 2 Further studies have suggested that inability to normalize filling pressures during speed adjustment confers a worse prognosis. 3 Even in the hands of LVAS-trained clinicians with the aid of real-time invasive haemodynamic data, over 40% of patients remain non-optimized after LVAS speed adjustment. Which patients will not benefit haemodynamically from speed increase remains unclear. Perhaps as importantly, why some patients cannot achieve optimization of filling pressures is unknown.
The role of respiratory variation for physiologic insight and prognosis is wellestablished for right-sided filling pressures as eponymously described by Kussmaul. 4 However, less information is available about the implications of left-sided filling pressure (e.g. PAWP) respiratory variation. This is likely due to the relative ease of investigating respirophasic changes of CVP on physical examination, and the ongoing operatorand institution-dependent inconsistency in how PAWP is reported in relation to the respiratory cycle during RHC. 5 In non-LVAS supported patients, elevated PAWP respirophasic variation (PAWP var ) correlates well with elevated respirophasic variation in left ventricular end-diastolic pressure. 6 However, it is unclear what prognostic or physiologic information this may impart. We examined PAWP var in LVAS patients undergoing invasive haemodynamic assessment at our institution. We hypothesized that the low PAWP var is associated with a relative inability to reduce PAWP with increasing pump speed.
This study complies with the Declaration of Helsinki and was approved by the MUSC Institutional Review Board. We retrospectively collected data from 23 separate, consecutive haemodynamic ramp studies performed on 17 LVAS patients [15 with HeartMate II, 2 with HeartMate 3 (Abbott Medical, Abbott Park, IL, USA)] at the Medical University of South Carolina between July 2016 and April 2018. All studies were performed by one of two heart failure/LVAS-trained physicians (R.J.T., B.A.H.) during spontaneous respiration in the absence of sedation, mechanical ventilation or inotropic support. All pressure waveforms at inspiration and expiration were retrospectively evaluated from digitally recorded waveforms by a trained observer (D.B.) in a blinded fashion -the observer did not know the end-result of the ramp study when measuring initial pressures. Expiratory PAWP (PAWP exp ) was measured by transecting the A-wave at end-expiration, and inspiratory PAWP (PAWP insp ) was measured by transecting the A-wave at end-inspiration. PAWP var was defined as PAWP exp -PAWP insp at the beginning of the test prior to any pump speed manipulation. PAWP for each ramp speed step was recorded as equal to PAWP exp . PAWP exp at the end of the study (highest LVAS speed) was subtracted from PAWP exp at the beginning of the study to calculate the total change in PAWP throughout the ramp speed study (PAWP Δramp ). Left ventricular transmural pressure (TMP LV ) was defined as initial PAWP exp -CVP exp . Continuous parameters were expressed as mean ± standard deviation and compared with Student's t-test; categorical parameters were expressed as frequency (percentage).
The mean age of our patients was 56 ± 10 years, 12 were male, 7 (41%) had ischaemic cardiomyopathy as an indication for LVAS, 11 (65%) had diabetes mellitus, and 6 (35%) had a diagnosis of chronic kidney disease, though none were on dialysis. Thirteen (76%) were implanted as destination therapy. All studies were done in the setting of sinus rhythm or atrioventricular sequential pacing; no patient had atrial fibrillation at the time of their study. Mean initial PAWP exp was 18.5 ± 7 mmHg and mean initial PAWP var was 8.3 ± 4.5 mmHg. Similar to prior reports, 2 12/23 (52%) studies started with a PAWP of ≥ 18 mmHg. Mean initial CVP was 12.7 ± 4 mmHg, and 14/23 (61%) studies started with a CVP ≥ 12 mmHg. Mean initial speed was 8972 ± 1031 rpm for the HeartMate II patients and 5400 ± 100 rpm for the HeartMate 3 patients. Mean total speed increase was 1173 ± 541 rpm (or 13.3 ± 5.7% above the baseline speed) for the HeartMate II patients and 650 ± 50 rpm (or 12% ± 1.1% above the baseline speed) for the HeartMate 3 patients.
PAWP var was strongly correlated with PAWP Δramp (R = 0.73) ( Figure 1A) . To investigate whether initial PAWP exp was itself a confounder (if patients with higher PAWP exp had greater PAWP var and therefore had a higher PAWP Δramp ), PAWP var and PAWP Δramp were both normalized as a percent of initial PAWP exp , and %PAWP var and %PAWP Δramp remained well-correlated (R = 0.52) ( Figure 1B) . PAWP Δramp was not correlated with total speed increase (R = 0.2) ( Figure 1C ...................................................................................................................................................................................................................................   ...................................................................................................................................................................................................................................... 
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Research letters negative PAWP Δramp and suggesting either measurement error or aortic insufficiency as aetiologic in their haemodynamic profile (though concomitant echocardiogram did not show worsening aortic insufficiency). Excluding this patient strengthened the correlation between PAWP var and PAWP Δramp (R = 0.77). There was no difference in body mass index comparing patients with PAWP var vs. less than or greater than median PAWP var (30.7 ± 3.4 vs. 33.9 ± 5.5, P = 0.12), nor was there difference in FEV 1 /FVC ratio on pulmonary function testing (77.4 ± 6% vs. 73 ± 6%, P = 0.11).
This study suggests that initial PAWP var correlates with the degree to which PAWP can be reduced with LVAS speed increase. Figure 2 illustrates two patients with similar initial PAWP exp values but with different initial PAWP var and subsequent PAWP Δramp values. This finding generates a physiologic hypothesis of the existence of a 'left-sided Kussmaul sign' in LVAS patients. Kussmaul's sign, or the absence of a decrement in CVP with inspiration, is associated with worse outcomes in heart failure patients. 4 Similarly, the inability to reduce the PAWP with LVAS speed increase is also associated with worse outcomes. 3 The correlation between PAWP Δramp and TMP LV suggests that biventricular interaction may play a role: patients with elevated PAWP and low CVP (high TMP LV ) have a higher PAWP var and PAWP Δramp , and conversely those with elevated PAWP and high CVP (low TMP LV ) have lower PAWP var and PAWP Δramp . One may hypothesize that the presence of a low TMP LV indicates the presence of a 'pseudoconstrictive' state due to increased cardiac volumes and/or right ventricular failure. Thus, as diastolic biventricular pressures near equalization (low TMP LV ), neither the negative intrathoracic pressure reduction of inspiration nor LVAS speed increase is able to unload the left ventricle optimally due to this 'pseudo-constrictive' state. Stated differently, as TMP LV declines, PAWP may no longer represent the effective distending pressure of the left ventricle, and thus PAWP could remain 'elevated' despite an unloaded left ventricle.
Our study is limited by the possible selection bias inherent in retrospective studies (though all LVAS patients sent for ramp study during the study period were included regardless of indication), and the unknown applicability of our findings for patients in atrial fibrillation. Future studies should seek to further validate this hypothesis-generating finding, explore the physiologic basis for 
